ALX and Sanofi partner to start Phase l/ll trial of RRMM combo therapy

cafead

Administrator
Staff member
  • cafead   Apr 26, 2023 at 10:42: AM
via ALX Oncology has reached a clinical trial partnership and supply agreement with Sanofi to assess evorpacept in combination with SARCLISA (isatuximab-irfc) and dexamethasone to treat patients with relapsed or refractory multiple myeloma (RRMM).

article source
 

<